CD163+ macrophages attenuate pressure overload-induced left ventricular systolic dysfunction and cardiac mitochondrial dysfunction via interleukin-10
- PMID: 40343453
- DOI: 10.1007/s00395-025-01114-z
CD163+ macrophages attenuate pressure overload-induced left ventricular systolic dysfunction and cardiac mitochondrial dysfunction via interleukin-10
Abstract
Macrophage depletion exacerbates pressure overload-induced heart failure, but therapeutic translation is hindered by macrophage subset heterogeneity. The functional role of CD163+ macrophages in heart failure remains unclear. Transverse aortic constriction (TAC) was employed to induce pressure overload. Cd163-/- mice exhibited significantly aggravated TAC-induced left ventricular systolic dysfunction, as demonstrated by reduced ejection fraction, fractional shortening, and global longitudinal strain, compared to wild-type (WT) controls. RNA sequencing of cardiac tissues revealed significant differential gene expression between TAC-treated WT and Cd163-/- mice, especially in pathways governing mitochondrial bioenergetics and homeostasis. Transmission electron microscopy confirmed greater accumulation of dysfunctional mitochondria in cardiomyocytes of Cd163-/- mice relative to WT following TAC. Additionally, the proportion of CD163+ macrophages among cardiac macrophages increased post-TAC. Serum IL-10 levels and cardiac macrophage IL-10 expression were significantly diminished in Cd163-/- mice compared to WT after TAC. IL-10 supplementation effectively reversed the TAC-induced impairment in left ventricular systolic function in both WT and Cd163-/- mice, and reduced NADH/NAD+ ratios, reduced mitochondrial dysfunction, and improved mitochondrial membrane potential in Cd163-/- mice. Cross-sectional clinical data supported these findings, showing decreased IL-10 levels as a significant risk factor for heart failure in hypertensive patients (odds ratio: 0.397; 95% CI 0.203-0.775; p = 0.007). Collectively, these results highlight the protective role of CD163+ macrophages against pressure overload-induced left ventricular dysfunction and mitochondrial dysfunction through IL-10-dependent pathways.
Keywords: CD163; Dysfunctional mitochondria; Heart failure; Interleukin-10; Pressure overload.
© 2025. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: None declared.
Similar articles
-
Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure.J Biomed Sci. 2025 Jul 6;32(1):61. doi: 10.1186/s12929-025-01162-6. J Biomed Sci. 2025. PMID: 40619438 Free PMC article.
-
CD206+IL-4Rα+ Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.Circulation. 2025 Jul 29;152(4):257-273. doi: 10.1161/CIRCULATIONAHA.124.072411. Epub 2025 May 1. Circulation. 2025. PMID: 40308203
-
The two-pore K+ channel TREK-1 regulates pressure overload-induced cardiac remodeling.Am J Physiol Heart Circ Physiol. 2025 Jul 1;329(1):H178-H190. doi: 10.1152/ajpheart.00821.2024. Epub 2025 May 19. Am J Physiol Heart Circ Physiol. 2025. PMID: 40387641 Free PMC article.
-
Hypertrophic heart failure promotes gut dysbiosis and gut leakage in interleukin 10-deficient mice.Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H447-H459. doi: 10.1152/ajpheart.00323.2024. Epub 2025 Jan 24. Am J Physiol Heart Circ Physiol. 2025. PMID: 39854049 Free PMC article.
-
Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.Circulation. 2025 Jul 22;152(3):183-201. doi: 10.1161/CIRCULATIONAHA.124.069737. Epub 2025 Jun 30. Circulation. 2025. PMID: 40583767
References
-
- Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, Epelman S, Kreisel D, Liu Y, Itoh A, Shankar TS, Selzman CH, Drakos SG, Lavine KJ (2018) The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med 24:1234–1245. https://doi.org/10.1038/s41591-018-0059-x - DOI - PubMed - PMC
-
- Bloom MW, Greenberg B, Jaarsma T, Januzzi JL, Lam CSP, Maggioni AP, Trochu J-N, Butler J (2017) Heart failure with reduced ejection fraction. Nat Rev Dis Primers 3:1–19. https://doi.org/10.1038/nrdp.2017.58 - DOI
-
- Chen L, Mei W, Song J, Chen K, Ni W, Wang L, Li Z, Ge X, Su L, Jiang C, Liu B, Dai C (2024) CD163 protein inhibits lipopolysaccharide-induced macrophage transformation from M2 to M1 involved in disruption of the TWEAK-Fn14 interaction. Heliyon 10:e23223. https://doi.org/10.1016/j.heliyon.2023.e23223 - DOI - PubMed
-
- Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, Chen S, Xu X, Huang S, Liu C (2024) Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Sig Transduct Target Ther 9:1–44. https://doi.org/10.1038/s41392-024-01840-1 - DOI
-
- Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, Duo Y (2023) Macrophages in immunoregulation and therapeutics. Sig Transduct Target Ther 8:1–35. https://doi.org/10.1038/s41392-023-01452-1 - DOI
MeSH terms
Substances
Grants and funding
- 2019YFE0113900/National Key Research and Development Program of China
- 3502Z20204005/Xiamen Medical and Health Key Project
- 2021QNB021/Fujian Provincial Health Technology Project
- 2023/Scientific Research Foundation of the Xiamen Human Resource Ministry for Returned Chinese Scholars
- 2024J011424/Natural Science Foundation of Fujian Province
LinkOut - more resources
Full Text Sources
Medical
Research Materials